APA (7th ed.) Citation

BG, K., N, B., W, W., GJR, C., A, S., M, N., . . . AG, R. (2026). Diagnostic performance of quantitative measures from [18F]FDG PET/CT, [18F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: Data from the MAPPING study. European journal of nuclear medicine and molecular imaging, 53(4), 2414. https://doi.org/10.1007/s00259-025-07587-3

Chicago Style (17th ed.) Citation

BG, King, et al. "Diagnostic Performance of Quantitative Measures from [18F]FDG PET/CT, [18F]FEC PET/CT, and DW-MRI in the Detection of Lymph Node Metastases in Endometrial and Cervical Cancer: Data from the MAPPING Study." European Journal of Nuclear Medicine and Molecular Imaging 53, no. 4 (2026): 2414. https://doi.org/10.1007/s00259-025-07587-3.

MLA (9th ed.) Citation

BG, King, et al. "Diagnostic Performance of Quantitative Measures from [18F]FDG PET/CT, [18F]FEC PET/CT, and DW-MRI in the Detection of Lymph Node Metastases in Endometrial and Cervical Cancer: Data from the MAPPING Study." European Journal of Nuclear Medicine and Molecular Imaging, vol. 53, no. 4, 2026, p. 2414, https://doi.org/10.1007/s00259-025-07587-3.